Deborah A Levine1, Dimitry S Davydow2, Catherine L Hough2, Kenneth M Langa2, Mary A M Rogers2, Theodore J Iwashyna2. 1. From the Department of Internal Medicine (D.A.L., K.M.L., M.A.M.R., T.J.I.) and the Department of Neurology and the Stroke Program (D.A.L.), University of Michigan, Ann Arbor; Veterans Affairs Center for Clinical Management Research, Ann Arbor, MI (D.A.L., K.M.L., T.J.I.); Department of Psychiatry and Behavioral Sciences (D.S.D.) and Department of Medicine, University of Washington, Seattle (C.L.H.); and Institute for Social Research, University of Michigan, Ann Arbor (K.M.L., T.J.I.). deblevin@umich.edu. 2. From the Department of Internal Medicine (D.A.L., K.M.L., M.A.M.R., T.J.I.) and the Department of Neurology and the Stroke Program (D.A.L.), University of Michigan, Ann Arbor; Veterans Affairs Center for Clinical Management Research, Ann Arbor, MI (D.A.L., K.M.L., T.J.I.); Department of Psychiatry and Behavioral Sciences (D.S.D.) and Department of Medicine, University of Washington, Seattle (C.L.H.); and Institute for Social Research, University of Michigan, Ann Arbor (K.M.L., T.J.I.).
Abstract
BACKGROUND: We assessed the acute and long-term effect of myocardial infarction (MI) and stroke on postevent functional disability and cognition while controlling for survivors' changes in functioning over the years before the event. METHODS AND RESULTS: Among participants in the nationally representative Health and Retirement Study with linked Medicare data (1998-2010), we determined within-person changes in functional limitations (basic and instrumental activities of daily living) and cognitive impairment after hospitalization for stroke (n=432) and MI (n=450), controlling for premorbid functioning using fixed-effects regression. In persons without baseline impairments, an acute MI yielded a mean acute increase of 0.41 functional limitations (95% confidence interval [CI], 0.18-0.63) with a linear increase of 0.14 limitations/year in the following decade. These increases were 0.65 limitations (95% CI, 0.07-1.23) and 0.27 limitations/year afterward for those with mild-to-moderate impairment at baseline. Stroke resulted in an acute increase of 2.07 (95% CI, 1.51-2.63) limitations because of the acute event and an increase of 0.15 limitations/year afterward for those unimpaired at baseline. There were 2.65 new limitations (95% CI, 1.86-3.44) and 0.19/year afterward for those with baseline mild-to-moderate impairment. Stroke hospitalization was associated with greater odds of moderate-to-severe cognitive impairment (odds ratio, 3.86; 95% CI, 2.10-7.11) at the time of the event, after adjustment for premorbid cognition but MI hospitalization was not. CONCLUSIONS: In this population-based cohort, most MI and stroke hospitalizations were associated with significant increases in functional disability at the time of the event and in the decade afterward. Survivors of MI and stroke warrant screening for functional disability over the long-term.
BACKGROUND: We assessed the acute and long-term effect of myocardial infarction (MI) and stroke on postevent functional disability and cognition while controlling for survivors' changes in functioning over the years before the event. METHODS AND RESULTS: Among participants in the nationally representative Health and Retirement Study with linked Medicare data (1998-2010), we determined within-person changes in functional limitations (basic and instrumental activities of daily living) and cognitive impairment after hospitalization for stroke (n=432) and MI (n=450), controlling for premorbid functioning using fixed-effects regression. In persons without baseline impairments, an acute MI yielded a mean acute increase of 0.41 functional limitations (95% confidence interval [CI], 0.18-0.63) with a linear increase of 0.14 limitations/year in the following decade. These increases were 0.65 limitations (95% CI, 0.07-1.23) and 0.27 limitations/year afterward for those with mild-to-moderate impairment at baseline. Stroke resulted in an acute increase of 2.07 (95% CI, 1.51-2.63) limitations because of the acute event and an increase of 0.15 limitations/year afterward for those unimpaired at baseline. There were 2.65 new limitations (95% CI, 1.86-3.44) and 0.19/year afterward for those with baseline mild-to-moderate impairment. Stroke hospitalization was associated with greater odds of moderate-to-severe cognitive impairment (odds ratio, 3.86; 95% CI, 2.10-7.11) at the time of the event, after adjustment for premorbid cognition but MI hospitalization was not. CONCLUSIONS: In this population-based cohort, most MI and stroke hospitalizations were associated with significant increases in functional disability at the time of the event and in the decade afterward. Survivors of MI and stroke warrant screening for functional disability over the long-term.
Authors: Amanda Sonnega; Jessica D Faul; Mary Beth Ofstedal; Kenneth M Langa; John W R Phillips; David R Weir Journal: Int J Epidemiol Date: 2014-03-25 Impact factor: 7.196
Authors: H Petrovitch; L White; K H Masaki; G W Ross; R D Abbott; B L Rodriguez; G Lu; C M Burchfiel; P L Blanchette; J D Curb Journal: Am J Cardiol Date: 1998-04-15 Impact factor: 2.778
Authors: Sarah E Vermeer; Niels D Prins; Tom den Heijer; Albert Hofman; Peter J Koudstaal; Monique M B Breteler Journal: N Engl J Med Date: 2003-03-27 Impact factor: 91.245
Authors: Dimitry S Davydow; Catherine L Hough; Deborah A Levine; Kenneth M Langa; Theodore J Iwashyna Journal: Am J Med Date: 2013-03-14 Impact factor: 4.965
Authors: Abdel Douiri; Christopher McKevitt; Eva S Emmett; Anthony G Rudd; Charles D A Wolfe Journal: Circulation Date: 2013-08-09 Impact factor: 29.690
Authors: C F Mendes de Leon; H M Krumholz; V Vaccarino; C S Williams; T A Glass; L F Berkman; S V Kas Journal: J Clin Epidemiol Date: 1998-07 Impact factor: 6.437
Authors: Deborah A Levine; Andrzej T Galecki; Kenneth M Langa; Frederick W Unverzagt; Mohammed U Kabeto; Bruno Giordani; Virginia G Wadley Journal: JAMA Date: 2015-07-07 Impact factor: 56.272
Authors: Jane S Saczynski; David D McManus; Molly E Waring; Darleen Lessard; Milena D Anatchkova; Jerry H Gurwitz; Jeroan Allison; Arlene S Ash; Richard H McManus; David C Parish; Robert J Goldberg; Catarina I Kiefe Journal: Circ Cardiovasc Qual Outcomes Date: 2017-12
Authors: Mandip S Dhamoon; W T Longstreth; Traci M Bartz; Robert C Kaplan; Mitchell S V Elkind Journal: JAMA Neurol Date: 2017-12-01 Impact factor: 18.302
Authors: George A Mensah; Ralph L Sacco; Barbara G Vickrey; Uchechukwu K A Sampson; Salina Waddy; Bruce Ovbiagele; Jeyaraj Durai Pandian; Bo Norrving; Valery L Feigin Journal: Neuroepidemiology Date: 2015-10-28 Impact factor: 3.282
Authors: Alexandra M Hajduk; Terrence E Murphy; Mary E Geda; John A Dodson; Sui Tsang; Leila Haghighat; Mary E Tinetti; Thomas M Gill; Sarwat I Chaudhry Journal: JAMA Intern Med Date: 2019-10-07 Impact factor: 21.873
Authors: Sarah K Schäfer; Robert Fleischmann; Bettina von Sarnowski; Dominic Bläsing; Agnes Flöel; Susanne Wurm Journal: BMJ Open Date: 2021-06-29 Impact factor: 2.692
Authors: Cameron J Gettel; Arjun K Venkatesh; Linda S Leo-Summers; Terrence E Murphy; Evelyne A Gahbauer; Ula Hwang; Thomas M Gill Journal: J Hosp Med Date: 2021-08 Impact factor: 2.899